XML 99 R84.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Segments (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2014
Segment Reporting Information [Line Items]      
Net sales $ 751,526 $ 748,591 $ 691,914
Depreciation and amortization 23,452 21,604 21,453
Adjusted EBITDA - Total segments 143,383 137,334 116,542
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 76,761 78,763 6,308
Interest expense, net 16,592 14,305 32,962
Depreciation and amortization 23,452 21,604 21,453
Acquisition-related cost of goods sold 2,566    
Acquisition-related accrued compensation 1,680 747  
Acquisition-related transaction costs 618
Loss on insurance claim 5,350
Foreign currency (gains) losses, net (7,609) (5,400) 1,753
Loss on extinguishment of debt     22,771
Adjusted EBITDA - Total segments 143,383 137,334 116,542
Identifiable assets 610,373 493,318  
Operating Segments      
Segment Reporting Information [Line Items]      
Net sales 751,526 748,591 691,914
Depreciation and amortization 20,423 18,475 18,264
Adjusted EBITDA - Total segments 143,383 137,334 116,542
Reconciliation of income before income taxes to Adjusted EBITDA      
Income before income taxes 76,761 78,763 6,308
Interest expense, net 16,592 14,305 32,962
Depreciation and amortization 20,423 18,475 18,264
Acquisition-related cost of goods sold 2,566 18,475 18,264
Acquisition-related accrued compensation 1,680 747  
Acquisition-related transaction costs 618
Loss on insurance claim 5,350
Foreign currency (gains) losses, net (7,609) (5,400) 1,753
Loss on extinguishment of debt     22,771
Adjusted EBITDA - Total segments 143,383 137,334 116,542
Identifiable assets 524,247 429,955  
Operating Segments | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 486,140 470,800 431,053
Depreciation and amortization 17,149 15,430 15,484
Adjusted EBITDA - Total segments 127,442 120,259 100,280
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 17,149 15,430 15,484
Adjusted EBITDA - Total segments 127,442 120,259 100,280
Identifiable assets 444,751 349,345  
Operating Segments | Mineral Nutrition      
Segment Reporting Information [Line Items]      
Net sales 216,685 227,102 201,599
Depreciation and amortization 2,467 2,468 2,368
Adjusted EBITDA - Total segments 14,971 14,429 11,636
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 2,467 2,468 2,368
Adjusted EBITDA - Total segments 14,971 14,429 11,636
Identifiable assets 57,939 58,722  
Operating Segments | Performance Products      
Segment Reporting Information [Line Items]      
Net sales 48,701 50,689 59,262
Depreciation and amortization 807 577 412
Adjusted EBITDA - Total segments 970 2,646 4,626
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 807 577 412
Adjusted EBITDA - Total segments 970 2,646 4,626
Identifiable assets 21,557 21,888  
Operating Segments | MFAs and other | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 339,916 335,735 326,568
Operating Segments | Nutritional specialties | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 94,084 81,702 63,068
Operating Segments | Vaccines | Animal Health      
Segment Reporting Information [Line Items]      
Net sales 52,140 53,363 41,417
Corporate      
Segment Reporting Information [Line Items]      
Depreciation and amortization 3,029 3,129 3,189
Adjusted EBITDA - Total segments 29,323 27,315 25,945
Reconciliation of income before income taxes to Adjusted EBITDA      
Depreciation and amortization 3,029 3,129 3,189
Adjusted EBITDA - Total segments 29,323 27,315 $ 25,945
Identifiable assets $ 86,126 $ 63,363